NCT03686722
- Conditions
- Blood-Borne Infections, Communicable Diseases, Diabetes Mellitus, +15 more
- Locations
-
- Drug research centre Cairo, Egypt
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,680 public trials
156 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT02589873
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
- Locations
-
- City and County of San Francisco San Francisco, California, United States
NCT01907854
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Tucson, Arizona, United States
- Novo Nordisk Investigational Site Tucson, Arizona, United States
Completed
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus
NCT00418522
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Tucson, Arizona, United States
- Pfizer Investigational Site Concord, California, United States
- Pfizer Investigational Site Encino, California, United States
Completed
Efficacy and Safety of Nutraceuticals in Patients With Diabetes Mellitus Type II and Dyslipidemia.
NCT03676309
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +9 more
- Locations
-
- Capomolla Antonio Monterosso Calabro, VV, Italy
NCT02738151
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Investigational Site Number 840038 Sheffield, Alabama, United States
- Investigational Site Number 840066 Phoenix, Arizona, United States
- Investigational Site Number 840051 Anaheim, California, United States
- Investigational Site Number 840081 Chino, California, United States
NCT02254291
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan
- Novo Nordisk Investigational Site Chitose, Hokkaido, Japan
- Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan
- Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan
NCT01059825
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
NCT01096667
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +6 more
- Locations
-
Not specified
NCT02648217
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Algiers, Algeria
- Novo Nordisk Investigational Site Oran, Algeria
- Novo Nordisk Investigational Site Sétif, Algeria
- Novo Nordisk Investigational Site Sidi Bel Abbes, Algeria